Effect of POSTbiotics Supplementation on Microbiome in OBese Children: the POST-OB Study

Childhood Obesity Clinical Trial

— POST-OB  

Official title:

Effect of POSTbiotics Supplementation on Microbiome in OBese Children: the POST-OB Study

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04151823
• Other study ID #: 2015/ST/135-2
• Status: Recruiting
• Phase: Phase 4
• Start date: January 7, 2019
• Est. completion date: January 7, 2021

Study information

• Verified date: July 2020
• Source: University of Milan
• Contact: Elvira Verduci, PhD
• Phone: 3934771218
• Email: elvira.verduci[@]unimi.it
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study evaluates the possible effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, on gut microbiota composition and metabolite production. It also wants to determine whether postbiotics supplementation, combined with interventions to improve diet and lifestyle, reduces adverse metabolic consequences together with their co‐morbidities.

All participants will follow a behaviour (promotion of physical activity) and dietary treatment according to Italian dietary guidelines for childhood obesity.

Postbiotics and vitamin D3 will be given orally for four months; patients will be evaluated four months after supplementation and diet-lifestyle intervention and four months after the end of supplementation and after the alone diet-lifestyle intervention with blood testing and echosonography of the liver.

Description:

25-30 Caucasian obese children will be enrolled at the Pediatric Department of San Paolo Hospital - University of Milan.

Stool samples from all enrolled patients at the different time points (t0, before supplementation and diet-lifestyle intervention, t1, four months after supplementation and diet-lifestyle intervention and t2 four months after the end of supplementation and after the alone diet-lifestyle intervention) will be collected and stored at -80°C until the following investigation:

1. study of the microbiota biodiversity by high-throughput sequencing techniques (16S rRNA gene sequencing) in order to establish whether postbiotics could modulate the microbial composition in obese children;

2. analysis of short chain fatty acids concentration by gas-chromatography (GC-FID) in order to monitor the effect of postbiotics intake modulating microbial metabolite production.

The following tasks will be also performed at t0, t1 and t2:

• Clinical examination including: physical examination, Tanner score evaluation; Bristol Stool Chart

• Blood pressure will be checked in all children by using oscillometric devices validated in the pediatric age group.

• Anthropometry including body circumferences and skinfolds, calculation of BMI z scores and body composition. Body composition will be assessed using an air displacement plethysmography system (BOD POD COSMED-USA).

• Dietary assessment:

1. Food intakes will be recorded by prospective 3-d weighed food records obtained with food scales. Parents will be advised on how to record all food and beverages consumed during 2 weekdays and 1 weekend day. Quantification and analysis of the energy intake and nutrient composition will be performed with an ad hoc PC software (MètaDieta®, Me.Te.Da S.r.l., San Benedetto del Tronto, Italy).

2. Mediterranean Diet Quality Index (KIDMED) questionnaire for Mediterranean Diet assessment. The KIDMED index ranges from 0 to 12, and is based on a 16-question test that can be self-administered. The sums of the values from the administered test will be classified into three levels:

1. 8 or more: optimal Mediterranean diet;

2. 4-7: improvement needed to adjust intake to Mediterranean patterns.

3. 3 or less: very low diet quality.

• Hematological and biochemical status including:

1. Complete cell blood count;

2. Metabolic and nutritional parameters according to local routines for childhood obesity (fasting glucose, fasting insulin, LDL, HDL, total cholesterol, triglycerides, Apolipoprotein A and Apolipoprotein B levels, transaminases and amma-glutamyl transferase). Oral Glucose Tolerance Test (OGTT) will be performed. The insulin sensitivity and insulin resistance was assessed by calculating HOMA index (Homeostasis Model Assessment) and QUICKI (Quantitative Insulin-Sensitivity Check Index), using the following formulas:

• HOMA: fasting plasma insulin in mU/l x FPG in mmol/l/22.5

• QUICKI: 1/(log10 fasting plasma insulin in mU/l + log10 glucose in mg/dl)

3. Inflammatory index (VES, high-sensitive CRP, including fecal calprotectin)

• Liver ultrasonography will be performed by a single evaluator.

All participants will follow a behavior (promotion of physical activity) and dietary treatment according to Italian dietary guidelines for childhood obesity.

Postbiotics will be given at the dose of 80 mg/day (2 ml per day SMART D3 MATRIX Smartfarma S.r.l. Via San Vittore 40 - 20123 MILAN; fermented fructooligosaccharides from Lactobacillus paracasei strain CNCM I-5220). 2 mk of product will give 1600 UI/die of VIT D3.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 30
• Est. completion date: January 7, 2021
• Est. primary completion date: January 7, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 6 Years to 14 Years

Eligibility

Inclusion Criteria:

• 6 <Age <14 years

• Severe obesity (>3 DS) according to WHO classification.

• Gestational age: 37-42 weeks.

• Birth-weight: > 2500 g e < 4000 g

• Caucasian

Exclusion Criteria:

• secondary obesity

• supplementation with pre/probiotics (in the previous 3 months);

• antibiotic treatment (in the previous 3 months);

• chronic or acute intestinal diseases (in the previous 3 months).

Related Conditions & MeSH terms

• Childhood Obesity
• Pediatric Obesity

Intervention

Drug:
• Vitamin D3
2 ml per day SMART D3 MATRIX Smartfarma S.r.l. Via San Vittore 40 - 20123 MILAN: 2 mL of product will give 1600 UI/die of VIT D3.
• Immunofos
Postbiotics will be given at the dose of 80 mg/day. immunofos from Lactobacillus paracasei CNCM I-5220).

Other:
• Promotion of physical activity
Promotion of physical activity will be encouraged at t0, t1, t2
• Healthy food habits promotion
Promotion of healthy food habits will be encouraged at t0, t1, t2

Locations

Country	Name	City	State
Italy	Ospedale San Paolo	Milan

Sponsors (1)

Lead Sponsor	Collaborator
University of Milan

Country where clinical trial is conducted

Italy, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Changes in gut microbiota composition	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Primary	Changes in short chain fatty acids production by gut microbiota	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in HDL-cholesterol levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in LDL-cholesterol levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in triglycerides levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in systemic arterial blood pressure	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in body mass index	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in Bristol stool chart	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in puberal stage	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in fasting glucose levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in fasting insulin levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in oral glucose tolerance test results	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in Apoprotein A1 levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in Apoprotein B levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in alanine aminotransferase (ALT) levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in aspartate aminotransferase (AST) levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in Gamma-glutamyl transferase (GGT) levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in complete cell blood count	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in total cholesterol levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in Homeostasis Model Assessment (HOMA) index	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in Quantitative Insulin-Sensitivity Check Index (QUICKI)	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in erythrocyte sedimentation rate (ESR)	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in C-reactive protein (CRP) levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in fecal calprotectin levels	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Echosonographic changes in liver morphology (degree of steatosis)	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in body mass composition assessed with air displacement plethysmography system	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in body circumference (waist, left arm)	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months
Secondary	Changes in body skinfold thickness (waist, posterior skinfold and anterior skinfold of left arm)	Effect of postbiotics supplementation, combined with interventions aimed at improving diet and lifestyle, will be evaluated. Difference in gut microbiota composition will be evaluated before starting supplementation (t0), at the end of supplementation (t1: +4 months) e after 4 months of dietary dietary-lifestyle intervention without supplementation (t2: +8 months).	t0: 0 t1: +4 months t2: +8 months